A preclinical research platform investigating programmable
genomic architectures and advanced molecular delivery
systems.





Neo Quantum Era delivers next-generation scientific solutions at the intersection of quantum biology, Prime Editing, and precision biotechnology. Our services are designed to accelerate discovery, enable scalable therapeutic development, and support translational research across health, longevity, and molecular science. We combine deep scientific expertise with advanced computational and biological platforms to transform complex challenges into clinically viable innovations.
Quantum Biology & Therapeutic Research
Advanced Longevity & Health Research
Molecular & Experimental Compound Development
Advanced Delivery & Formulation Science
Custom Scientific Solutions

fits Innovation + Biotech themes.

perfect for Quantum Bio Research or Experimental Solutions.
Neo Quantum Era is a research-driven biotechnology
initiative focused on structured genomic engineering
exploration and translational system design.
Mechanistic clarity
Iterative experimental evaluation
Responsible innovation
Regulatory pathway awareness
We prioritize disciplined architecture development within
preclinical research environments.
Neo Quantum Era is a research-focused biotechnology initiative developing structured preclinical genomic engineering architectures within controlled laboratory
environments.
Our work integrates programmable editing methodologies, engineered nanoscale material systems, intracellular targeting optimization research, and computational modeling rrameworks.
We approach biotechnology as a systems discipline emphasizing architecture design, feasibility evaluation, and responsible translational planning.
ZPE-77 is an exploratory research platform designed to evaluate programmable genomic modulation strategies and non-viral molecular transport systems
Current investigative priorities include editing fidelity characterization, delivery system behavior modeling, targeting efficiency assessment, and scalability and
manufacturability analysis.
All technologies described remain investigational and in
preclinical development.
Our research philosophy prioritizes mechanistic clarity,
iterative experimental refinement, risk modeling, regulatory
pathway awareness, and structured translational planning.
Neo Quantum Era focuses on feasibility evaluation rather
than therapeutic claims.
Neo Quantum Era focuses on quantum-inspired biotechnology, advanced molecular research, and next-generation scientific exploration aimed at supporting innovation in health, longevity, and biological systems.
We work with research institutions, biotechnology companies, laboratories, and scientific partners seeking advanced experimental methodologies and research support.
Our work is research-driven and intended for scientific, experimental, and exploratory purposes. We do not provide direct medical treatments or consumer healthcare services.
Our methodologies emphasize accuracy, transparency, and advanced technological frameworks, supported by interdisciplinary expertise and rigorous scientific protocols.
You can explore our research focus areas on the website or reach out to discuss potential collaboration opportunities and custom research solutions.
Market segments: aging, cancer, neurodegeneration, ophthalmology, and sports medicine.
Strong proposition with significant downstream clinical translation value.
Strong proposition with significant downstream clinical translation value.
Strategic collaboration on scale-up of ZPE-X components
(pegRNA, peptide, mRNA, LNP).
Co-development of future formulations
(e.g., ZPE-QNCOGEN, ZPE-NCURO).
Shared visibility in regulatory filings and intellectual property expansion.
Pilot manufacturing and laboratory partnership for clinical advancement.
PE2 mRNA — Prime Editor enzyme for precise, one-time genomic editing.
NeoMod-1 Recombinant Peptide
Proprietary regenerative modulator.
PFAP2 Field-Stabilizing Peptide — Enhances quantum field coherence and stability.
ZPE-X is a next-generation therapeutic platform driven by quantum biology and Prime Editing.
Engineered to promote multi-system regeneration, repair, and cellular optimization.
Powered by the proprietary peptide NeoMod-1, gold-nanoparticle delivery, and pegRNA integration.

2046 Adam Clayton Powell Jr Blvd, , New York 10027


(929) 448-9599